Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliquaâ„¢) in Patients With Type 2 Diabetes Mellitus (T2DM)